Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome

Altered dosage of developmental regulators such as transcription factors can result in disorders, such as FOXG1 syndrome. Here, the authors demonstrate the utility of SMASh technology for modulating protein dosage by modeling FOXG1 syndrome using human pluripotent stem cell-derived neurons and neura...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wenliang Zhu, Boya Zhang, Mengqi Li, Fan Mo, Tingwei Mi, Yihui Wu, Zhaoqian Teng, Qi Zhou, Wei Li, Baoyang Hu
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/fe289d2c0c864031a37e09fb8593c020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fe289d2c0c864031a37e09fb8593c020
record_format dspace
spelling oai:doaj.org-article:fe289d2c0c864031a37e09fb8593c0202021-12-02T16:58:06ZPrecisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome10.1038/s41467-019-08841-72041-1723https://doaj.org/article/fe289d2c0c864031a37e09fb8593c0202019-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-08841-7https://doaj.org/toc/2041-1723Altered dosage of developmental regulators such as transcription factors can result in disorders, such as FOXG1 syndrome. Here, the authors demonstrate the utility of SMASh technology for modulating protein dosage by modeling FOXG1 syndrome using human pluripotent stem cell-derived neurons and neural organoids.Wenliang ZhuBoya ZhangMengqi LiFan MoTingwei MiYihui WuZhaoqian TengQi ZhouWei LiBaoyang HuNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-18 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Wenliang Zhu
Boya Zhang
Mengqi Li
Fan Mo
Tingwei Mi
Yihui Wu
Zhaoqian Teng
Qi Zhou
Wei Li
Baoyang Hu
Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
description Altered dosage of developmental regulators such as transcription factors can result in disorders, such as FOXG1 syndrome. Here, the authors demonstrate the utility of SMASh technology for modulating protein dosage by modeling FOXG1 syndrome using human pluripotent stem cell-derived neurons and neural organoids.
format article
author Wenliang Zhu
Boya Zhang
Mengqi Li
Fan Mo
Tingwei Mi
Yihui Wu
Zhaoqian Teng
Qi Zhou
Wei Li
Baoyang Hu
author_facet Wenliang Zhu
Boya Zhang
Mengqi Li
Fan Mo
Tingwei Mi
Yihui Wu
Zhaoqian Teng
Qi Zhou
Wei Li
Baoyang Hu
author_sort Wenliang Zhu
title Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
title_short Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
title_full Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
title_fullStr Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
title_full_unstemmed Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome
title_sort precisely controlling endogenous protein dosage in hpscs and derivatives to model foxg1 syndrome
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/fe289d2c0c864031a37e09fb8593c020
work_keys_str_mv AT wenliangzhu preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT boyazhang preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT mengqili preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT fanmo preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT tingweimi preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT yihuiwu preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT zhaoqianteng preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT qizhou preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT weili preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
AT baoyanghu preciselycontrollingendogenousproteindosageinhpscsandderivativestomodelfoxg1syndrome
_version_ 1718382425236570112